Virax Biolabs Group Limited (NASDAQ:VRAX – Get Rating)'s share price rose 119.4% during mid-day trading on Monday . The stock traded as high as $13.75 and last traded at $11.85. Approximately 57,188,768 shares changed hands during trading, an increase of 415% from the average daily volume of 11,097,444 shares. The stock had previously closed at $5.40.

Virax Biolabs Group Stock Performance

About Virax Biolabs Group

(Get Rating)

Virax Biolabs Group Limited, a biotechnology company, sells, distributes, and markets diagnostics test kits, and med-tech and PPE products for the prevention, detection, diagnosis, and risk management of viral diseases in the field of immunology. The company offers rapid antibody IgC/IgM tests, antigen tests, polymerase chain reaction rapid tests, and neutralizing antibody tests under the ViraxClear brand name; and med-tech and PPE products, such as employee protection equipment products under the ViraxCare brand name.

Further Reading

• Get a free copy of the StockNews.com research report on Virax Biolabs Group (VRAX)
• Proposed Tesla Stock Split Drives EV Market Higher
• AutoNation Stock is Firing on All Pistons
• Is Nike An Undervalued Opportunity for Investors?
• Caterpillar Falls To Strong Support Near Bottom Of Range
• AMD Q2 Earnings Beat Expectations Significantly, Is AMD A Buy?

Receive News & Ratings for Virax Biolabs Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Virax Biolabs Group and related companies with MarketBeat.com's FREE daily email newsletter.